Apogee Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $48M | 1.2M | 39.73 |
| 2025-06-30 | $22M | 507k | 43.43 |
| 2025-03-31 | $3.5M | 94k | 37.36 |
| 2024-12-31 | $3.6M | 78k | 45.30 |
| 2024-09-30 | $517k | 8.8k | 58.74 |
| 2024-06-30 | $5.0M | 126k | 39.35 |
| 2024-03-31 | $352k | 5.3k | 66.45 |
| 2023-09-30 | $5.2M | 243k | 21.30 |